Selank

CLASSIFICATION Anxiolytic Peptide
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Deus Medical
LAB TEST See Document
WAREHOUSE EU Warehouse 2
SUBSTANCE Selank Anxiolytic Peptide

In the exciting world of biotechnology, innovative biologically active compounds are emerging, with "cognitive enhancers" or "nootropics" leading the charge. One standout in this category is Selank, previously known as ?TP-7.? This remarkable synthetic peptide, a small, engineered protein, is gaining attention for its potential benefits.

Renowned for its anti-anxiety properties, Selank is also believed to enhance learning and boost energy levels?without the risk of adverse effects or addiction. Developed through a collaboration between the Institute of Molecular Genetics and the V.V. Zakusov Research Institute of Pharmacology in Russia, Selank is closely related to another drug called Semax.

Selank is synthesized by combining a peptide called tuftsin, which is found in the antibody IgG, with a sequence that stabilizes its molecular structure. Research indicates that both tuftsin and Selank can effectively reduce anxiety and elevate serotonin levels in animal studies, with Selank often showing superior results.

In Russia, Selank is approved for treating generalized anxiety disorder (GAD) and as a nootropic, although the FDA has not sanctioned its use for any medical conditions. Nonetheless, Selank remains available in various countries, commonly marketed as a "nutritional supplement."

While the exact mechanisms of Selank are not fully understood, it is believed to play a role in stabilizing enkephalins in the bloodstream?natural peptides that can help diminish the body's stress response. Some studies suggest Selank interacts with GABA receptors, typically linked to sedative effects, potentially resulting in decreased brain activity consistent with sedation.

Interestingly, some researchers have observed an increase in BDNF, a crucial neurotropic factor associated with learning and memory, which may shed light on Selank's cognitive benefits. Additionally, Selank appears to influence neurotransmitter levels?norepinephrine, dopamine, and serotonin?all vital for motivation, focus, and pleasure.

However, findings from various studies present a mixed picture of Selank's effects on these neurotransmitters, indicating a need for further investigation to clarify its mechanisms.

A preliminary clinical trial involving 62 participants indicated that Selank reduced anxiety symptoms, particularly in those with existing anxiety disorders. Another study with 60 individuals demonstrated similar benefits lasting up to a week after the last dose. Moreover, Selank was found to enhance the effects of phenazepam (an anti-anxiety medication) while mitigating side effects like drowsiness and memory loss. Animal studies further support Selank's potential to alleviate anxiety, especially in mice with heightened anxiety levels.

While evidence remains limited, these findings suggest Selank may offer relief from anxiety. However, further research is needed to confirm its efficacy and safety in humans. If you experience anxiety, consult with your healthcare provider to determine if Selank could be beneficial for you, but always follow their guidance rather than substituting any supplements.

Selank has also shown promise in stabilizing memory traces in rats, potentially enhancing memory retention, although the methods for evaluating memory remain ambiguous. Additionally, it may aid memory preservation in monkeys, but more human studies are warranted to assess its effects on healthy individuals and its safety.

In one study, Selank treatment restored normal brain activity in rats with toxin-induced brain damage.

Selank demonstrated the ability to reduce depressive symptoms in mice, with lower doses proving more effective than higher ones.

Preliminary animal research indicated that Selank injections elevated antioxidant levels in the livers of stressed mice.

In a study involving sedated cats, Selank reduced blood pressure by around 30% for up to three minutes and increased cerebral blood flow by about 24% for up to ten minutes. While these initial findings are intriguing, their transient nature complicates clinical relevance and raises questions about applicability to healthy humans.

In a study simulating alcohol withdrawal, rats that consumed a 10% ethanol solution for 24 weeks exhibited reduced anxiety when treated with Selank after a 48-hour withdrawal.

Another study found that rats on a high-fat diet experienced 35% less weight gain with Selank treatment, alongside significant reductions in total cholesterol and blood glucose levels.

In one study, Selank treatment slowed tumor growth in mice with breast cancer, although these preliminary results do not validate its use as an anticancer therapy, and more research is essential.

Following Selank treatment, mouse spleens exhibited increased levels of inflammatory response genes, suggesting some protective effects against inflammation.

Research indicates that Selank can reduce stomach ulcer size in animal models, potentially due to enhanced lymph flow to the stomach. However, substantial human studies are necessary to confirm these effects.

Selank has been associated with increased IL-6 levels in blood cells from depressed patients, with IL-6 playing a role in infection defense. However, an animal study did not show any antiviral benefits from Selank treatment, necessitating further investigation.